비용종을 동반한 만성 부비동염 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 9.0%의 성장률(CAGR)로 62억 1,000만 달러에 달할 것으로 예측됩니다. 예측 기간의 성장은 생물학적 치료의 확대, 개인 맞춤형 의료 증가, 기술 발전, 규제 당국의 승인 증가, 환자 중심 의료의 확대, 역학 동향 모니터링 등에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 혁신적인 약물 전달 시스템, 병태생리 이해, 임상시험, 종단 연구, 인지도 향상, 통합 치료 모델, 유병률, 발생률 등이 있습니다.
호흡기 질환의 유병률 증가는 비용종을 동반한 만성 부비동염 시장의 성장을 가속할 것으로 예측됩니다. 이러한 질병은 폐 및 호흡기와 같은 호흡기 계통에 영향을 미치며 대기 오염, 흡연, 기후 변화, 감염, 직업적 노출, 알레르기 등의 요인에 의해 영향을 받습니다. 천식, 만성폐쇄성폐질환(COPD)과 같은 질병은 점점 더 흔해지고 있으며, CRSwNP와 같은 관련 질환의 이환율 상승으로 이어지고 있습니다. 이러한 추세는 진단 도구, 치료 및 수술적 개입에 대한 수요를 촉진하고 있습니다. 예를 들어, 미국 국립보건통계센터(NCHS)의 최근 자료에 따르면 미국 성인의 천식 유병률은 2021년 8.4%에서 2022년 8.7%로 증가할 것으로 예상되며, 같은 기간 천식 에피소드는 3.3%에서 3.7%로 증가할 것으로 예상되고 있습니다. 호흡기 감염이 확산됨에 따라 비용종을 동반한 만성 부비동염 시장의 성장은 더욱 촉진될 것으로 예측됩니다.
비용종을 동반한 만성 부비동염 시장의 주요 기업들은 환자의 예후를 개선하고 경쟁력을 강화하기 위해 항 IL-5 생물학적 제제와 같은 대체 요법을 우선시하고 있습니다. 항 IL-5 생물학적 제제는 중증 천식 및 호산구 질환과 같은 질환에서 호산구 염증을 억제하여 환자의 증상 조절과 삶의 질을 향상시키는 표적 치료를 제공합니다. 예를 들어, 2024년 3월, 혁신적인 제품 개발 및 상용화에 주력하는 미국 제약회사 옵티노스(Optinose)는 성인 만성 비부비동염(CRS)을 적응증으로 하는 처방용 비강 점비제 XHANCE의 미국 식품의약국(FDA) 승인을 획득했습니다. 비강 내 염증을 억제하는 코르티코스테로이드인 플루티카손 프로피온산 에스테르를 함유하고 있습니다. 주요 특징은 독특한 호기 전달 시스템(EDS)으로, 환자가 스프레이를 투여하는 동안 장치를 향해 숨을 내쉴 수 있어 비강 깊숙이 약물 전달을 강화하여 비용종이 형성되고 부비동에서 배출되는 부위를 효과적으로 타겟팅할 수 있다는 점입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계비용종을 동반한 만성 부비동염 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 비용종을 동반한 만성 부비동염 시장 : 성장률 분석
- 세계의 비용종을 동반한 만성 부비동염 시장 실적 : 규모와 성장, 2019-2024
- 세계의 비용종을 동반한 만성 부비동염 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계비용종을 동반한 만성 부비동염 전체 시장(TAM)
제6장 시장 세분화
- 세계의 비용종을 동반한 만성 부비동염 시장 : 치료별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 의약품
- 수술
- 세계의 비용종을 동반한 만성 부비동염 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 비강
- 경구
- 기타 투여 경로
- 세계의 비용종을 동반한 만성 부비동염 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원 약국
- 소매 약국
- 온라인 약국
- 세계의 비용종을 동반한 만성 부비동염 시장 : 의약품 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 코르티코스테로이드(비강 스프레이, 경구 스테로이드)
- 생물학적 제제(Dupilumab과 같은 단클론항체)
- 항생제
- 항히스타민제
- 류코트리엔 조절제
- 세계의 비용종을 동반한 만성 부비동염 시장 : 수술 방법 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 내시경하 부비강 수술(ESS)
- 폴립 절제술(폴립 제거)
- 풍선 부비동 성형술
제7장 지역별/국가별 분석
- 세계의 비용종을 동반한 만성 부비동염 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 비용종을 동반한 만성 부비동염 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 비용종을 동반한 만성 부비동염 시장 : 경쟁 구도
- 비용종을 동반한 만성 부비동염 시장 : 기업 개요
- Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis
- Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Bristol-Myers Squibb Company
- AstraZeneca PLC
- Novartis AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Medtronic plc
- Boehringer Ingelheim International GmbH
- Amgen Inc
- Teva Pharmaceutical Industries Ltd
- Regeneron Pharmaceuticals Inc
- Daiichi Sankyo Company Limited
- Olympus Corporation
- Eisai Co Ltd
- Smith & Nephew PLC
- Genentech USA Inc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 비용종을 동반한 만성 부비동염 시장(2029년) : 새로운 기회를 제공하는 국가
- 비용종을 동반한 만성 부비동염 시장(2029년) : 새로운 기회를 제공하는 부문
- 비용종을 동반한 만성 부비동염 시장(2029년) : 성장 전략
제36장 부록
LSH
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) is an enduring inflammatory condition affecting the sinuses and nasal passages, characterized by the development of nasal polyps. These polyps are benign, swollen tissues that form in response to ongoing inflammation in the nasal passages or sinuses. Diagnosis typically involves evaluating symptoms, conducting clinical examinations, utilizing imaging techniques, allergy tests, and occasionally performing biopsies.
The primary treatments for chronic rhinosinusitis with nasal polyps encompass both pharmaceutical and surgical approaches. Medications aim to alleviate inflammation, manage symptoms, and reduce the size of polyps. They can be administered via nasal sprays, orally, or through other routes, and are available through hospital pharmacies, retail outlets, and online platforms.
The chronic rhinosinusitis with nasal polyps market research report is one of a series of new reports from the business research company that provides chronic rhinosinusitis with nasal polyps market statistics, including chronic rhinosinusitis with nasal polyps industry global market size, regional shares, competitors with an chronic rhinosinusitis with nasal polyps market share, detailed chronic rhinosinusitis with nasal polyps market segments, market trends and opportunities, and any further data you may need to thrive in the chronic rhinosinusitis with nasal polyps industry. This chronic rhinosinusitis with nasal polyps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The chronic rhinosinusitis with nasal polyps market size has grown strongly in recent years. It will grow from $4.02 billion in 2024 to $4.4 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to increasing prevalence, growing advancements in diagnosis, increasing treatment innovation, growing patient awareness, and increasing healthcare spending.
The chronic rhinosinusitis with nasal polyps market size is expected to see strong growth in the next few years. It will grow to $6.21 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to growing biologic therapies, increasing personalized medicine, advancing technological advancements, increasing regulatory approvals, growing patient-centric care, and monitoring epidemiological trends. Major trends in the forecast period include innovative drug delivery systems, understanding pathophysiology, clinical trials, longitudinal studies, increased awareness, integrated care models, prevalence, and incidence.
The rising prevalence of respiratory diseases is expected to drive growth in the chronic rhinosinusitis with nasal polyps market. These diseases affect the respiratory system, including the lungs and airways, and are influenced by factors such as air pollution, smoking, climate change, infections, occupational exposures, and allergies. Conditions such as asthma and chronic obstructive pulmonary disease (COPD) are increasingly common, leading to higher rates of associated conditions such as CRSwNP. This trend is fueling demand for diagnostic tools, treatments, and surgical interventions. For example, recent data from the National Center for Health Statistics (NCHS) shows an increase in asthma prevalence among U.S. adults from 8.4% in 2021 to 8.7% in 2022, with asthma episodes rising from 3.3% to 3.7% over the same period. As respiratory tract infections become more prevalent, they are expected to further stimulate growth in the chronic rhinosinusitis with nasal polyps market.
Leading companies in the chronic rhinosinusitis with nasal polyps market are prioritizing alternative therapies, such as anti-IL-5 biologics, to improve patient outcomes and strengthen their competitive edge. Anti-IL-5 biologics provide targeted treatment by reducing eosinophilic inflammation in conditions like severe asthma and eosinophilic disorders, enhancing symptom control and quality of life for patients. For instance, in March 2024, Optinose, a U.S.-based pharmaceutical company focused on developing and commercializing innovative products, received U.S. Food and Drug Administration (FDA) approval for XHANCE, a prescription nasal spray indicated for chronic rhinosinusitis (CRS) in adults, including both chronic rhinosinusitis with nasal polyps (CRSwNP) and without nasal polyps (CRSsNP). It contains fluticasone propionate, a corticosteroid that reduces nasal passage inflammation. A key feature is its unique Exhalation Delivery System (EDS), enabling patients to exhale into the device while administering the spray, which enhances medication delivery deep into the nasal passages, effectively targeting areas where nasal polyps form and sinuses drain.
In May 2022, Medtronic Plc, a US-based medical technology solutions company, completed the acquisition of Intersect ENT Inc. for an undisclosed amount. The acquisition adds Intersect ENT's PROPEL and SINUVA sinus implant product lines and technology to Medtronic's existing ear, nose, and throat (ENT) portfolio. Intersect ENT Inc. is a US-based medical technology company specializing in treating chronic rhinosinusitis with nasal polyps.
Major companies operating in the chronic rhinosinusitis with nasal polyps market are Pfizer Inc., Roche Holding AG, Merck & Co Inc, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Medtronic plc, Boehringer Ingelheim International GmbH, Amgen Inc, Teva Pharmaceutical Industries Ltd, Regeneron Pharmaceuticals Inc, Daiichi Sankyo Company Limited, Olympus Corporation, Eisai Co Ltd, Smith & Nephew PLC, Genentech USA Inc, Mallinckrodt Pharmaceuticals, Lyra Therapeutics Inc, Sunovion Pharmaceuticals, Acclarent Inc., Optinose US Inc, SinuSys Corporation, Biohaven Pharmaceuticals
North America was the largest region in the chronic rhinosinusitis with nasal polyps market in 2024. The regions covered in the chronic rhinosinusitis with nasal polyps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the chronic rhinosinusitis with nasal polyps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The chronic rhinosinusitis with nasal polyps market consists of revenues earned by entities by providing services such as medical consultations, diagnostic procedures, pharmacological treatments, and surgical interventions. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic rhinosinusitis with nasal polyps market also includes sales of nasal corticosteroid sprays, antihistamines, saline nasal sprays, and devices for nasal irrigation, as well as surgical instruments and equipment used in procedures such as polypectomy and functional endoscopic sinus surgery. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Chronic Rhinosinusitis With Nasal Polyps Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on chronic rhinosinusitis with nasal polyps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for chronic rhinosinusitis with nasal polyps ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic rhinosinusitis with nasal polyps market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Treatment: Medications; Surgical Methods
- 2) By Route Of Administration: Nasal; Oral; Other Routes Of Administration
- 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
- Subsegments:
- 1) By Medications: Corticosteroids (Nasal Sprays, Oral Steroids); Biologics (Monoclonal Antibodies Like Dupilumab); Antibiotics; Antihistamines; Leukotriene Modifiers
- 2) By Surgical Methods: Endoscopic Sinus Surgery (ESS); Polypectomy (Polyps Removal); Balloon Sinuplasty
- Companies Mentioned: Pfizer Inc.; Roche Holding AG; Merck & Co Inc; Bayer AG; Sanofi SA
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Chronic Rhinosinusitis With Nasal Polyps Market Characteristics
3. Chronic Rhinosinusitis With Nasal Polyps Market Trends And Strategies
4. Chronic Rhinosinusitis With Nasal Polyps Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Chronic Rhinosinusitis With Nasal Polyps Growth Analysis And Strategic Analysis Framework
- 5.1. Global Chronic Rhinosinusitis With Nasal Polyps PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Chronic Rhinosinusitis With Nasal Polyps Market Growth Rate Analysis
- 5.4. Global Chronic Rhinosinusitis With Nasal Polyps Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Chronic Rhinosinusitis With Nasal Polyps Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Chronic Rhinosinusitis With Nasal Polyps Total Addressable Market (TAM)
6. Chronic Rhinosinusitis With Nasal Polyps Market Segmentation
- 6.1. Global Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Medications
- Surgical Methods
- 6.2. Global Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nasal
- Oral
- Other Routes Of Administration
- 6.3. Global Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- 6.4. Global Chronic Rhinosinusitis With Nasal Polyps Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Corticosteroids (Nasal Sprays, Oral Steroids)
- Biologics (Monoclonal Antibodies Like Dupilumab)
- Antibiotics
- Antihistamines
- Leukotriene Modifiers
- 6.5. Global Chronic Rhinosinusitis With Nasal Polyps Market, Sub-Segmentation Of Surgical Methods, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Endoscopic Sinus Surgery (ESS)
- Polypectomy (Polyps Removal)
- Balloon Sinuplasty
7. Chronic Rhinosinusitis With Nasal Polyps Market Regional And Country Analysis
- 7.1. Global Chronic Rhinosinusitis With Nasal Polyps Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Chronic Rhinosinusitis With Nasal Polyps Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market
- 8.1. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Chronic Rhinosinusitis With Nasal Polyps Market
- 9.1. China Chronic Rhinosinusitis With Nasal Polyps Market Overview
- 9.2. China Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Chronic Rhinosinusitis With Nasal Polyps Market
- 10.1. India Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Chronic Rhinosinusitis With Nasal Polyps Market
- 11.1. Japan Chronic Rhinosinusitis With Nasal Polyps Market Overview
- 11.2. Japan Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Chronic Rhinosinusitis With Nasal Polyps Market
- 12.1. Australia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market
- 13.1. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Chronic Rhinosinusitis With Nasal Polyps Market
- 14.1. South Korea Chronic Rhinosinusitis With Nasal Polyps Market Overview
- 14.2. South Korea Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market
- 15.1. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market Overview
- 15.2. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Chronic Rhinosinusitis With Nasal Polyps Market
- 16.1. UK Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Chronic Rhinosinusitis With Nasal Polyps Market
- 17.1. Germany Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Chronic Rhinosinusitis With Nasal Polyps Market
- 18.1. France Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Chronic Rhinosinusitis With Nasal Polyps Market
- 19.1. Italy Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Chronic Rhinosinusitis With Nasal Polyps Market
- 20.1. Spain Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market
- 21.1. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market Overview
- 21.2. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Chronic Rhinosinusitis With Nasal Polyps Market
- 22.1. Russia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Chronic Rhinosinusitis With Nasal Polyps Market
- 23.1. North America Chronic Rhinosinusitis With Nasal Polyps Market Overview
- 23.2. North America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Chronic Rhinosinusitis With Nasal Polyps Market
- 24.1. USA Chronic Rhinosinusitis With Nasal Polyps Market Overview
- 24.2. USA Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Chronic Rhinosinusitis With Nasal Polyps Market
- 25.1. Canada Chronic Rhinosinusitis With Nasal Polyps Market Overview
- 25.2. Canada Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Chronic Rhinosinusitis With Nasal Polyps Market
- 26.1. South America Chronic Rhinosinusitis With Nasal Polyps Market Overview
- 26.2. South America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Chronic Rhinosinusitis With Nasal Polyps Market
- 27.1. Brazil Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Chronic Rhinosinusitis With Nasal Polyps Market
- 28.1. Middle East Chronic Rhinosinusitis With Nasal Polyps Market Overview
- 28.2. Middle East Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Chronic Rhinosinusitis With Nasal Polyps Market
- 29.1. Africa Chronic Rhinosinusitis With Nasal Polyps Market Overview
- 29.2. Africa Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Chronic Rhinosinusitis With Nasal Polyps Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Chronic Rhinosinusitis With Nasal Polyps Market Competitive Landscape And Company Profiles
- 30.1. Chronic Rhinosinusitis With Nasal Polyps Market Competitive Landscape
- 30.2. Chronic Rhinosinusitis With Nasal Polyps Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
31. Chronic Rhinosinusitis With Nasal Polyps Market Other Major And Innovative Companies
- 31.1. Bristol-Myers Squibb Company
- 31.2. AstraZeneca PLC
- 31.3. Novartis AG
- 31.4. GlaxoSmithKline plc
- 31.5. Takeda Pharmaceutical Company Limited
- 31.6. Medtronic plc
- 31.7. Boehringer Ingelheim International GmbH
- 31.8. Amgen Inc
- 31.9. Teva Pharmaceutical Industries Ltd
- 31.10. Regeneron Pharmaceuticals Inc
- 31.11. Daiichi Sankyo Company Limited
- 31.12. Olympus Corporation
- 31.13. Eisai Co Ltd
- 31.14. Smith & Nephew PLC
- 31.15. Genentech USA Inc
32. Global Chronic Rhinosinusitis With Nasal Polyps Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Chronic Rhinosinusitis With Nasal Polyps Market
34. Recent Developments In The Chronic Rhinosinusitis With Nasal Polyps Market
35. Chronic Rhinosinusitis With Nasal Polyps Market High Potential Countries, Segments and Strategies
- 35.1 Chronic Rhinosinusitis With Nasal Polyps Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Chronic Rhinosinusitis With Nasal Polyps Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Chronic Rhinosinusitis With Nasal Polyps Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
